References
- Ikeda S, Nakazato M, Ando Y, Sobue G. Familial amyloid polyneuropathy in Japan: Cinical and genetic heterogeneity. Neurology 2002; 58: 1001–1007
- Benson M D, Uemichi T. Transthyretin amyloidosis. Amyloid: Int J Exp Clin Invest 1996; 3: 44–56
- Connors L H, Richardson A M, Theberge R, Costello C E. Tabulation of transthyretin (TTR) variants as of l/l/ 2000. Amyloid: Int J Exp Clin Invest 2000; 7: 54–69
- Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, Takahashi M, Ishihara T. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001; 51: 264–270
- Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li Y F, Masuda Y, Ikeda S. Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid: Int J Exp Clin Invest 1999; 6: 282–288
- Rukavina J G, Block W D, Jackson C E, Falls H F, Carey J H, Curtis A C. Primary systemic amyloidosis: a review and an experimental, genetic, and clinical study of 29 cases with particular emphasis on the familial form. Medicine 1956; 35: 239–344
- Zeldenrust S R, Skinner M, Skare J, Benson M D. A new transthyretin variant (His 69) associated with vitreous amyloid in an FAP family. Amyloid: Int J Exp Clin Invest 1994; 1: 17–22
- Averof M, Rokas A, Wolfe K H, Sharp P M. Evidence for a high frequency of simultaneous double‐nucleotide substitutions. Science 2000; 287: 1283–1286
- Strahler J R, Rosenbium B B, Hanash S M. Identification and characterization of a human transthyretin variant. Biochem Biophys Res Commun 1987; 148: 471–477